IBIO iBio, Inc.

iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.

$0.26  -0.01 (-5.00%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/04/2011
Outstanding shares:  218,165,624
Average volume:  4,242,078
Market cap:   $61,435,440
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BG43QY2
Valuation   (See tab for details)
PE ratio:   -1.82
PB ratio:   0.76
PS ratio:   21.84
Return on equity:   -41.74%
Net income %:   -1,177.85%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy